Results 221 to 230 of about 48,894 (301)

The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO study. [PDF]

Am J Health Syst Pharm
Malone DC, Seheult R, Brixner D, Oderda G, Burnett BP, Biskupiak J.   +5 more
europepmc   +1 more source

Periodontitis, Edentulism, and Risk of Inflammatory Bowel Disease (IBD): A Systematic Review With Meta‐Analysis

Journal of Periodontal Research, EarlyView.
This systematic review with meta‐analyzes evaluated the relationship between periodontitis, severe periodontitis, edentulism, and inflammatory bowel disease (IBD). While longitudinal studies suggested a modest association mainly with ulcerative colitis, cross‐sectional evidence consistently supported the coexistence of periodontal disease and IBD ...
Mario Aimetti, Giacomo Tonello, Vivek Thumbigere‐Math, Davide Giuseppe Ribaldone, Mario Romandini, Federica Romano, Giacomo Baima   +6 more
wiley   +1 more source

Comparative risk of psoriatic arthritis in psoriasis patients on immunomodulators. [PDF]

Proc (Bayl Univ Med Cent)
Schmidt M, Dowdle TS, Golovko G, Munoz A.   +3 more
europepmc   +1 more source

Tunnel Technique With Connective Tissue Graft Versus Free Gingival Graft for Multiple Gingival Recessions in the Anterior Mandible: A Randomized Clinical Trial

Journal of Periodontal Research, EarlyView.
Both techniques were effective in treating multiple mandibular gingival recessions, resulting in a significant reduction in recession depth after 12 months. Free gingival graft showed a more predictable approach for keratinized tissue gain. In contrast, the tunnel technique was superior in healing outcomes.
Marcela Iunes da Silveira, Jovânia Alves Oliveira, Roberta de Oliveira Alves, Gabriel Marques Araújo, Guilherme José Pimentel Lopes de Oliveira, Suzane Cristina Pigossi   +5 more
wiley   +1 more source

Positioning of advanced therapies in patients with moderate-to-severe Crohn's disease. [PDF]

Singapore Med J
Qiu TY, Tan CK, Ong JPL, Ling KL.
europepmc   +1 more source

Breaking the sound barrier: global monoclonal antibody pharmacoequity. [PDF]

Front Pediatr
Gelderblom HC, Gray G, Kelley B.
europepmc   +1 more source

Inflammation and mechanical force‐induced bone remodeling

Periodontology 2000, EarlyView.
Abstract Periodontitis arises from imbalanced host–microbe interactions, leading to dysbiosis and destructive inflammation. The host's innate and adaptive immune responses produce pro‐inflammatory mediators that stimulate destructive events, which cause loss of alveolar bone and connective tissue attachment.
Hyeran Helen Jeon, Xin Huang, Leticia Rojas Cortez, Puttipong Sripinun, Jung‐me Lee, Julie J. Hong, Dana T. Graves   +6 more
wiley   +1 more source

FUT2 non-secretor status is not associated with disease phenotype or outcomes in patients with Crohn's disease. [PDF]

Crohns Colitis 360
Lombard R, Wang W, Chervonsky A, Dalal S, Cohen RD, Sakuraba A, Rubin DT, Weber CR, Pekow J.   +8 more
europepmc   +1 more source

Antibiotic‐mediated immune modulation in periodontitis

Periodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez, R. M. Arce, Camila Pinheiro Furquim, Cristiane Gonçalves, Alpdogan Kantarci, Magda Feres, Nidia C. Castro dos Santos   +6 more
wiley   +1 more source

Risk assessment of drug-associated miscarriage using XGBoost and SHAP explainability: a real-world pharmacovigilance analysis based on the FAERS database. [PDF]

Front Pharmacol
Lin S, Ma L, Zhao R, Peng L, Zhang X, Zhang B, Li D, Li Y, He L.   +8 more
europepmc   +1 more source